Cardiac Biomarkers Flashcards

1
Q

What is Acute Coronary Syndrome (ACS)?

A

Acute heart condition due to coronary atherosclerosis complications, including unstable angina, NSTEMI, and STEMI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the difference between ACS and MI?

A

Myocardial infarction (MI) is a type of ACS characterized by myocardial necrosis. ACS includes both MI and unstable angina.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two types of MI?

A

NSTEMI (Non-ST Elevation MI) – No Q waves on ECG.
STEMI (ST Elevation MI) – Q waves present on ECG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do diabetic patients often not feel pain in an MI?

A

Due to autonomic neuropathy, which reduces pain sensation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the three main cardiac biomarkers used in acute MI?

A

Troponin, Myoglobin, NT-proBNP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When is Troponin (cTn) used?

A

Gold standard for MI diagnosis. Highly specific for cardiac muscle injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When is Myoglobin used?

A

Early biomarker (1st hour after pain) but low specificity (elevates in muscle injury).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is NT-proBNP used?

A

For chronic heart failure (CHF) assessment and severity monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why is time important in MI diagnosis?

A

Cardiac muscle does not regenerate, so early intervention is crucial.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the main advantage of Myoglobin?

A

Early detection of MI (first hour).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the main disadvantage of Myoglobin?

A

Low specificity (also elevated in trauma, kidney disease, etc.).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do Troponin and Myoglobin differ?

A

Troponin is highly specific for MI, while Myoglobin rises early but lacks specificity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the role of BNP/NT-proBNP in heart failure?

A

BNP = Chronic heart failure biomarker. Higher BNP = Worse heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is ultra-sensitive Troponin (cTnUs) better than conventional Troponin?

A

Detects smaller variations, allowing for earlier MI diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the first step when a patient presents with chest pain?

A

Interrogation – Ask when the pain started to assess muscle damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is knowing the time of pain onset important?

A

The earlier the intervention, the more myocardium can be saved.

17
Q

What are the two types of Coronary Syndromes based on ECG?

A

ST-elevated (STEMI) vs Non-ST elevated (NSTEMI).

18
Q

How do we classify an ST-positive or ST-negative MI in practice?

A

ST-positive = STEMI
ST-negative = NSTEMI or Unstable Angina

19
Q

What is the function of Troponin I & T in muscle contraction?

A

They regulate actin-myosin interaction, allowing cardiac muscle contraction.

20
Q

What is the role of Creatine Kinase-MB (CK-MB)?

A

Rises in MI but less specific than Troponin.

21
Q

What is the key marker for assessing necrosis size in MI?

A

Troponin levels correlate with infarct size.

22
Q

When should we use BNP/NT-proBNP?

A

To assess heart failure severity and prognosis.

23
Q

What is the main role of BNP in heart failure?

A

BNP is released when the heart is overstretched, promoting diuresis & vasodilation.

24
Q

What are validated indications for BNP/NT-proBNP?

A
  • Differentiate cardiac vs. pulmonary dyspnea
    • Monitor heart failure progression
    • Assess risk & treatment efficacy
25
Q

Why are lower decision values important in troponin testing?

A

They increase sensitivity, improving early detection of MI.

26
Q

Why is research on new biomarkers important?

A

To improve early diagnosis and treatment of cardiovascular diseases.

27
Q
  1. A 65-year-old diabetic patient presents with mild fatigue but no chest pain. ECG shows ST elevation. Lab tests:
    * Troponin T: 1.5 µg/L (elevated)
    * Myoglobin: 80 µg/L (borderline high)
    * NT-proBNP: 5000 pg/mL (high)
    What is the diagnosis, and what steps should be taken?
A

Diagnosis: Silent MI (due to diabetes) with underlying heart failure.
Next steps:
* Urgent angiography
* Revascularization (PCI or thrombolysis)
* Monitor BNP for heart failure management